Brief: EQL: In-License Seven Products For Denmark

EQL Pharma AB

15/03/2021 14:12

March 15 (Reuters) - EQL Pharma AB  EQL.TE :
    * EQL IN-LICENSE SEVEN PRODUCTS FOR DENMARK
    * ALL PRODUCTS ARE PRESCRIPTION-ONLY AND HAVE BETWEEN ONE
AND
THREE ACTIVE COMPETITORS, EXCLUDING EQL
    * SALES START IS EXPECTED IN EQL PHARMA'S FIRST FINANCIAL
QUARTER
2021/22
    * TOTAL TURNOVER IN MARKETS WHERE THESE PRODUCTS COMPETE IS
SLIGHTLY MORE THAN 50MDKK (2020)

Source text for Eikon:  ID:nWkr2FdXSJ 
Further company coverage:  EQL.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))